NYSE
EVH

Evolent Health Inc

Health Information Services
Healthcare

Prices are adjusted according to historical splits.

Evolent Health Inc Stock Price

Vitals

Today's Low:
$25.53
Today's High:
$26.08
Open Price:
$25.82
52W Low:
$21.832
52W High:
$39.779
Prev. Close:
$25.9
Volume:
813007

Company Statistics

Market Cap.:
$3.57 billion
Book Value:
10.104
Revenue TTM:
$1.48 billion
Operating Margin TTM:
0.8%
Gross Profit TTM:
$316.58 million
Profit Margin:
-2.28%
Return on Assets TTM:
0.38%
Return on Equity TTM:
-3.85%

Company Profile

Evolent Health Inc had its IPO on 2015-06-05 under the ticker symbol EVH.

The company operates in the Healthcare sector and Health Information Services industry. Evolent Health Inc has a staff strength of 5,100 employees.

Stock update

Shares of Evolent Health Inc opened at $25.82 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $25.53 - $26.08, and closed at $25.7.

This is a -0.77% slip from the previous day's closing price.

A total volume of 813,007 shares were traded at the close of the day’s session.

In the last one week, shares of Evolent Health Inc have slipped by -1.46%.

Evolent Health Inc's Key Ratios

Evolent Health Inc has a market cap of $3.57 billion, indicating a price to book ratio of 3.3272 and a price to sales ratio of 2.2532.

In the last 12-months Evolent Health Inc’s revenue was $1.48 billion with a gross profit of $316.58 million and an EBITDA of $66.15 million. The EBITDA ratio measures Evolent Health Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Evolent Health Inc’s operating margin was 0.8% while its return on assets stood at 0.38% with a return of equity of -3.85%.

In Q1, Evolent Health Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 44%.

Evolent Health Inc’s PE and PEG Ratio

Forward PE
32.6797
Trailing PE
0
PEG
-1.37

Its diluted EPS in the last 12-months stands at $-0.4 per share while it has a forward price to earnings multiple of 32.6797 and a PEG multiple of -1.37. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Evolent Health Inc’s profitability.

Evolent Health Inc stock is trading at a EV to sales ratio of 2.602 and a EV to EBITDA ratio of 109.9277. Its price to sales ratio in the trailing 12-months stood at 2.2532.

Evolent Health Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$2.59 billion
Total Liabilities
$51.01 million
Operating Cash Flow
$-394993000.00
Capital Expenditure
$9.06 million
Dividend Payout Ratio
0%

Evolent Health Inc ended 2024 with $2.59 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.59 billion while shareholder equity stood at $1.12 billion.

Evolent Health Inc ended 2024 with $36.28 million in deferred long-term liabilities, $51.01 million in other current liabilities, 170625000.00 in common stock, $-626136000.00 in retained earnings and $1.12 billion in goodwill. Its cash balance stood at $157.52 million and cash and short-term investments were $157.52 million. The company’s total short-term debt was $4,608,000 while long-term debt stood at $632.28 million.

Evolent Health Inc’s total current assets stands at $475.97 million while long-term investments were $4.11 million and short-term investments were $34.45 million. Its net receivables were $279.26 million compared to accounts payable of $51.01 million and inventory worth $0.

In 2024, Evolent Health Inc's operating cash flow was $-394993000.00 while its capital expenditure stood at $9.06 million.

Comparatively, Evolent Health Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$25.7
52-Week High
$39.779
52-Week Low
$21.832
Analyst Target Price
$47.25

Evolent Health Inc stock is currently trading at $25.7 per share. It touched a 52-week high of $39.779 and a 52-week low of $39.779. Analysts tracking the stock have a 12-month average target price of $47.25.

Its 50-day moving average was $28.12 and 200-day moving average was $30.44 The short ratio stood at 6.1 indicating a short percent outstanding of 0%.

Around 1185.8% of the company’s stock are held by insiders while 9293.8% are held by institutions.

Frequently Asked Questions About Evolent Health Inc

The stock symbol (also called stock or share ticker) of Evolent Health Inc is EVH

The IPO of Evolent Health Inc took place on 2015-06-05

Similar Industry Stocks (Health Information Services)

Last Price
Chg
Chg%
$40.09
0.19
+0.48%
$17.6
-0.06
-0.34%
$4.14
0.01
+0.24%
$2.27
0.01
+0.44%
$29.65
-0.6
-1.98%
$41.67
0.15
+0.36%
Matson Inc (MATX)
$86.1
0.9
+1.06%
Yelp Inc (YELP)
$44.08
0.1
+0.23%
$0.27
-0.02
-5.36%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Address

800 North Glebe Road, Arlington, VA, United States, 22203